U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188311188311Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid TumorsTerminatedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: ifosfamide|Drug: O6-benzylguaninehttps://ClinicalTrials.gov/show/NCT00086970
188312188312Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast CancerCompletedNo Results AvailableBreast CancerBiological: trastuzumab|Drug: docetaxel|Drug: gefitinibhttps://ClinicalTrials.gov/show/NCT00086957
188313188313Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaCompletedNo Results AvailableRecurrent Adult Diffuse Large Cell Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell LymphomaBiological: oblimersen sodium|Biological: rituximab|Drug: ifosfamide|Drug: carboplatin|Drug: etoposide|Biological: filgrastim|Biological: pegfilgrastim|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00086944
188314188314Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the RectumCompletedNo Results AvailableColorectal CancerDrug: capecitabine|Drug: oxaliplatin|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00086931
188315188315Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNo Results AvailableOvarian Cancer|Primary Peritoneal Cavity CancerBiological: cetuximab|Drug: carboplatinhttps://ClinicalTrials.gov/show/NCT00086892
188316188316Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: carmustine|Drug: erlotinib hydrochloride|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT00086879
188317188317Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With SurgeryActive, not recruitingNo Results AvailableMelanoma (Skin)Biological: D1/3-MAGE-3-His fusion protein|Biological: SB-AS02B adjuvant|Biological: SB-AS15 adjuvanthttps://ClinicalTrials.gov/show/NCT00086866
188318188318CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaTerminatedNo Results AvailableRecurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Refractory Chronic Lymphocytic LeukemiaDrug: temsirolimus|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00086840
188319188319Romidepsin in Treating Patients With Relapsed Small Cell Lung CancerCompletedNo Results AvailableRecurrent Small Cell Lung CancerDrug: romidepsin|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00086827
188320188320Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's LymphomaCompletedNo Results AvailableLymphomaDrug: doxorubicin hydrochloride|Drug: gemcitabine hydrochloride|Drug: vinblastinehttps://ClinicalTrials.gov/show/NCT00086801
188321188321Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic LeukemiaCompletedNo Results AvailableLeukemiaBiological: alemtuzumab|Biological: rituximab|Drug: fludarabine phosphatehttps://ClinicalTrials.gov/show/NCT00086775
188322188322Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid TumorsActive, not recruitingNo Results AvailableChemotherapy-induced Nausea and Vomiting|Unspecified Adult Solid Tumor, Protocol Specific|Breast Cancer|Gastrointestinal Cancer|Disease (or Disorder); Gynecological|Prostate CancerBehavioral: MR Therapy|Behavioral: Relaxing Music (RM) Therapy|Behavioral: Standard Symptom Management|Behavioral: Questionnaireshttps://ClinicalTrials.gov/show/NCT00086762
188323188323Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast CancerCompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00086749
188324188324Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical ProstatectomyCompletedNo Results AvailableProstate CancerDrug: bicalutamide|Drug: eflornithine|Drug: oral eflornithine placebo|Drug: oral bicalutamide placebohttps://ClinicalTrials.gov/show/NCT00086736
188325188325In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic CancerCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificBiological: recombinant tissue plasminogen activator|Drug: captoprilhttps://ClinicalTrials.gov/show/NCT00086723
188326188326Study of Enfuvirtide in HIV-Positive SubjectsCompletedNo Results AvailableHIV Infections|AIDSDrug: Fuzeonhttps://ClinicalTrials.gov/show/NCT00086710
188327188327Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial CystitisTerminatedHas ResultsInterstitial CystitisDrug: Pentosan polysulfate sodium 100 mg|Drug: Placebo|Drug: Pentosan polysulfate sodium 100 mghttps://ClinicalTrials.gov/show/NCT00086684
188328188328Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)CompletedNo Results AvailableMultiple SclerosisDrug: ABT-874/Human monoclonal antibody against IL-12|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00086671
188329188329Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)CompletedNo Results AvailableHypereosinophilia|Hypereosinophilic SyndromeDrug: mepolizumabhttps://ClinicalTrials.gov/show/NCT00086658
188330188330Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)CompletedNo Results AvailableAutistic DisorderDrug: citalopram hydrobromidehttps://ClinicalTrials.gov/show/NCT00086645
188331188331Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer TreatmentTerminatedNo Results AvailableOvarian CancerDrug: oregovomabhttps://ClinicalTrials.gov/show/NCT00086632
188332188332Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal WomenCompletedHas ResultsPostmenopausal Osteoporosis|OsteoporosisDrug: synthetic hPTH 1-34https://ClinicalTrials.gov/show/NCT00086619
188333188333A Safety and Efficacy Study of Xolair in Peanut AllergyTerminatedNo Results AvailableAllergyDrug: Xolair (omalizumab)https://ClinicalTrials.gov/show/NCT00086606
188334188334Study Of An FDA-approved Drug As Additional Therapy In Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: lamotriginehttps://ClinicalTrials.gov/show/NCT00086593
188335188335Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) PatientsCompletedHas ResultsB-Cell Chronic Lymphocytic LeukemiaBiological: FluCAM [Fludara + Campath]|Biological: fludarabine phosphatehttps://ClinicalTrials.gov/show/NCT00086580
188336188336Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube CancersCompletedNo Results AvailableFallopian Tube Cancer|Peritoneal Neoplasms|Epithelial Ovarian Cancerhttps://ClinicalTrials.gov/show/NCT00086567
188337188337Collection of Specimens for Study of Inflammatory Bowel DiseaseCompletedNo Results AvailableInflammatory Bowel Diseaseshttps://ClinicalTrials.gov/show/NCT00086554
188338188338Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNo Results AvailableChronic Hepatitis CDrug: Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wkshttps://ClinicalTrials.gov/show/NCT00086541
188339188339Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid TumorsCompletedNo Results AvailableCancerDrug: XL647https://ClinicalTrials.gov/show/NCT00086528
188340188340Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)CompletedHas ResultsDiabetes Mellitus, Type IIDrug: Sitagliptin (MK0431)|Drug: Placebo/Glipizide 5 mg|Drug: Metformin|Drug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT00086515

* Görseller ve İçerik tekif hakkına sahip olabilir